Search by Drug Name or NDC
NDC 63868-0949-01 Feminine Anti-Itch Creme 5.67; .85 g/28g; g/28g Details
Feminine Anti-Itch Creme 5.67; .85 g/28g; g/28g
Feminine Anti-Itch Creme is a TOPICAL CREAM in the HUMAN OTC DRUG category. It is labeled and distributed by Quality Choice (CHAIN DRUG MARKETING ASSOCIATION). The primary component is BENZOCAINE; RESORCINOL.
Product Information
| NDC | 63868-0949 |
|---|---|
| Product ID | 63868-949_f5391ab7-dcf9-a88d-e053-2a95a90a5fa6 |
| Associated GPIs | |
| GCN Sequence Number | 077124 |
| GCN Sequence Number Description | benzocaine/resorcinol CREAM (G) 20 %-3 % TOPICAL |
| HIC3 | Q5H |
| HIC3 Description | TOPICAL LOCAL ANESTHETICS |
| GCN | 43024 |
| HICL Sequence Number | 003246 |
| HICL Sequence Number Description | BENZOCAINE/RESORCINOL |
| Brand/Generic | Generic |
| Proprietary Name | Feminine Anti-Itch Creme |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | BENZOCAINE, RESORCINOL |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | CREAM |
| Route | TOPICAL |
| Active Ingredient Strength | 5.67; .85 |
| Active Ingredient Units | g/28g; g/28g |
| Substance Name | BENZOCAINE; RESORCINOL |
| Labeler Name | Quality Choice (CHAIN DRUG MARKETING ASSOCIATION) |
| Pharmaceutical Class | Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC] |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH NOT FINAL |
| Application Number | part348 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 63868-0949-01 (63868094901)
| NDC Package Code | 63868-949-01 |
|---|---|
| Billing NDC | 63868094901 |
| Package | 28 g in 1 TUBE (63868-949-01) |
| Marketing Start Date | 2020-02-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |